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Abstract  Early-onset  dementias  are  deﬁned  by  onset  of  ﬁrst  symptoms  before  the  age  of  65.
They  have  speciﬁc  diagnostic  features  which  differ  from  those  of  elderly  patients  in  terms  of
their  many  causes  and  atypical  clinical  presentations.  MRI  is  an  essential  procedure  for  identi-
fying  the  underlying  cause  of  the  dementia  (degenerative,  vascular,  infectious,  inﬂammatory,
metabolic  or  toxic).  Clinical  clues  and  MRI  signs  are  described,  and  their  deﬁning  features
are  related  to  the  young  age  of  the  patients  concerned.  Diagnostic  algorithms  are  proposed
from  signs  which  can  be  seen  on  the  different  MRI  sequences  (T1-weighted  volume  acquisition,
T2-weighted  FLAIR  sequences,  T2-weighted  gradient-echo,  diffusion-weighted  imaging).  Once
obvious  causes  have  been  excluded,  MRI  can  point  towards  the  rarer  causes  of  dementia  which
are  characteristic  in  young  people  (particularly  metabolic  and  autoimmune)  and  which  require
speciﬁc  management  and  genetic  counseling.
©  2013  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Early-onset  dementias  are  deﬁned  by  the  onset  of  initial  symptoms  before  the  age  of  65
years  old.  They  are  major  clinical  and  social  problems  with  devastating  consequences  on
patients  and  their  families.  The  average  prevalence  of  dementia  under  the  age  of  65  years
old  is  80  per  100,000  people  and  increases  from  the  age  of  55  onwards  [1].  Patients  whose
disease  started  before  the  age  of  60  make  up  8%  of  ‘‘memory’’  consultations  and  26%  of
the  French  Memory  Resource  and  Research  Centre  (CMRR)  consultations  [2].  Early-onset
dementia  has  speciﬁc  diagnostic  features  compared  to  dementia  in  the  elderly.  It  has
more  causes  and  can  present  atypically  with  a  wide  range  of  behavioral,  cognitive,  psychi-
atric  and  neurological  problems.  After  excluding  the  obvious  causes  (traumatic,  vascular,
progression  of  known  neurological  disease),  the  diagnostic  approach  involves  combining
clinical  ﬁndings,  family  history  and  imaging  appearances  in  order  to  identify  the  cause  of
the  dementia  and,  particularly,  to  identify  some  of  the  rare  metabolic  and  autoimmune
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In  the  amnesic  forms  of  the  disease,  atrophy  successively78  
auses,  which  require  speciﬁc  management  and/or  genetic
ounseling [3].  Magnetic  resonance  imaging  (MRI)  plays  a
undamental role  in  this  etiological  investigation.  The  aim
f this  investigation  is  to  establish  the  etiological  features  of
arious early-onset  dementias,  to  demonstrate  their  imaging
eatures on  MRI  and  to  offer  diagnostic  algorithms  based  on
he signs  which  may  be  seen.
iagnostic approach
he  causes  of  dementia  developing  before  the  age  of  65
an be  divided  into  different  groups:  degenerative  and
ascular diseases,  and  toxic,  infectious,  inﬂammatory  or
etabolic causes.  The  causes  become  more  similar  to  those
f patients  aged  over  65  years  old  as  patient  age  increases,
he commonest  causes  being  Alzheimer’s  disease  (AD),  vas-
ular  dementias  and  frontotemporal  lobar  degeneration
FTLD) (Fig.  1)  [4].  Genetic  and  metabolic  causes  become
ncreasingly common  the  earlier  the  dementia  starts  [5].
he clinical  presentation  in  adolescents  and  young  adults
s usually  as  a  ‘‘dementia  plus  syndrome’’  in  which  cog-
itive disorders  are  combined  with  assorted  neurological
roblems [6].  The  standard  MRI  investigation  protocol  for
he young  is  the  same  as  for  any  dementia  (French  National
ealth Authority  guidelines,  2011  [7])  with  T1-weighted
olume acquisitions,  axial  T2-weighted  FLAIR  sequences,
2-weighted gradient-echo,  diffusion  and  coronal  sections
erpendicular to  the  hippocampus  by  T2-weighted  spin  echo
RI. Depending  on  the  abnormalities  which  are  found,  addi-
ional MR  sequences  may  be  performed  (gadolinium  chelate
nhancement, MR  angiography  or  spectroscopy).
The  ‘‘secondary’’  dementias  (due  to  tumors,  trauma  or
hronic adult  hydrocephalus)  and  those  which  represent  the
ate stage  of  neurological  disorders,  which  do  not  raise  fur-
her diagnostic  difﬁculties,  have  been  excluded  from  this
eview.
egenerative diseaseshilst  AD  and  FTLD  are  the  most  common  degenerative
auses of  early-onset  dementia  (except  in  people  under
5 years  old)  [8],  the  clinical  and  imaging  features  may
igure 1. Distribution of the main causes of early-onset dementia.
a
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iffer  in  comparison  to  the  same  diseases  presenting  in  older
eople.
lzheimer’s disease
lzheimer’s  disease  is  responsible  for  30  to  40%  of  cases
f dementia  under  the  age  of  65  years  old  [4,8].  Clinical
igns usually  begin  around  the  age  of  40  although  the  prob-
ems may  develop  from  the  age  of  25  [6,9,10]  in  autosomal
ominant inherited  forms  of  the  disease  [11].  These  genetic
orms account  for  less  than  1%  of  AD,  and  are  mostly  due
o a  mutation  of  the  presenilin-1  gene  (PSEN1)  which  is
ocated on  chromosome  14.  The  mutation  may  also  involve
he APP  gene  which  codes  for  the  amyloid    precursor  pro-
ein on  chromosome  21  (this  was  initially  studied  because  of
he signiﬁcantly  increased  incidence  of  young  forms  of  AD
n patients  with  Down  Syndrome  [12]).  It  often  has  atypi-
al clinical  features  in  young  people.  The  diagnostic  criteria
or the  disease  recognize  amnesic  and  non-amnesic  presen-
ations amongst  the  cognitive  disorders  [13].  One  third  of
he cases  involve  non-amnesic  disease,  compared  to  only
% of  cases  in  patients  over  65  years  old.  The  non-amnesic
orms of  the  disease  are  characterized  by  visuo-spatial  prob-
ems in  focal  parieto-occipital  disease  (Benson’s  syndrome)
14] and  by  language  difﬁculties  (logopenic  aphasia)  [15,16].
he new  diagnostic  criteria  for  AD  [17]  highlight  the  impor-
ance of  new  biomarkers  (cerebrospinal  ﬂuid  [CSF]  markers,
orphological and  functional  imaging)  in  making  an  early
iagnosis. Three  types  of  biological  marker  found  in  CSF
re currently  used:  1-42  (A42)  amyloid  protein,  levels  of
hich are  reduced  in  AD  and  total  (T-tau)  and  phosphory-
ated (P-tau)  tau  proteins,  levels  of  which  are  increased  in
D [18].  According  to  Hansson  et  al.,  a  combination  of  T-tau
nd A42  concentrations  has  a  sensitivity  of  95%  and  speci-
city of  83%  in  the  detection  of  pre-dementia  AD  [19].  More
ecently, Bateman  et  al.  have  shown  that  CSF  A42  levels
all 25  years  before  and  that  tau  protein  levels  increase  15
ears before  the  ﬁrst  clinical  signs  [20]  in  patients  suffering
rom autosomal  dominant  forms  of  AD.ffects the  pre-entorhinal  cortex,  the  entorhinal  cortex,  the
ippocampi and  then  the  temporal  cortices  (anterior,  infe-
ior and  then  middle)  [21],  the  primary  associative,  visual
of  MR
v
t
[
b
t
l
a
d
f
n
p
t
a
t
t
n
n
d
M
f
l
c
a
s
[
e
i
a
a
l
s
aEarly-onset  dementias:  Speciﬁc  etiologies  and  contribution  
and/or  the  motor  cortical  regions  (Fig.  2)  [22].  Routine  clin-
ical investigation  for  hippocampal  atrophy  is  still  based  on
visual analysis  alone  (Scheltens  classiﬁcation)  [23].  A  study
of people  at  risk  of  familial  AD  has  shown  that  loss  of  volume
of hippocampal  structures  precedes  the  onset  of  symptoms
by several  years  [24].  Whilst,  typically,  the  hippocampal
regions are  initially  affected  in  the  elderly,  these  may  appear
normal at  the  onset  of  the  disease  in  young  people  [6].
Disease is  found  predominantly  in  the  posterior  cortical
regions in  parieto-occipital  forms  of  the  disease  with  bilat-
eral parietal  or  bilateral  parietal  and  occipital  atrophy  [25].
First-pass gadolinium  enhancement  techniques  and  Arterial
Spin Labeling  (ASL)  can  demonstrate  a  reduction  in  cerebral
blood ﬂow  in  the  posterior  parietal  cingulate  regions  at  an
early stage  (Fig.  3)  [26—28].
In  classic  amnesic  forms  of  AD,  positron  emission
tomography (18-FDG  PET-CT)  and  Monophoton  Emission
Computed Tomography  (MECT)  show  hypometabolism  and
hypoperfusion respectively,  successively  affecting  the
temporal regions,  the  posterior  cingulate  cortex,  the  tem-
poroparietal cortex  and  then  the  frontal  regions  [29].
Molecular imaging  techniques  which  directly  reﬂect  the
disease process  are  developing  at  an  astonishing  rate,
although access  to  these  techniques  is  still  limited.  Pitts-
burgh compound  B  [11C]-PIB  and  [18F]-AV45  markers  show  up
amyloid plaques,  and  [18F]-FDDNP  highlights  neuroﬁbrillary
degeneration and  amyloid  plaques  [30].  Increased  [11C]-PIB
uptake is  reported  to  be  visible  15  years  before  the  onset  of
symptoms in  autosomal  dominant  AD  [20].
Fronto-temporal lobar degeneration
FTLD  is  a  group  of  diseases  characterized  by  frontal  atro-
phy of  the  frontal  and  temporal  lobes.  It  is  the  third  leading
cause of  dementia  in  the  young  [4],  with  a  usual  age  of  onset
of symptoms  between  45  and  60  years  old  [31].  A  family
history of  dementia  is  reported  in  40%  of  cases  [32]  half
of which  are  transmitted  as  an  autosomal  recessive  disease
[33,34] and  the  clinical  presentation  within  families  is  often
s
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Figure 2. A 40-year-old man suffering from Alzheimer’s disease. Fam
large increase in size of the subarachnoid spaces predominantly affectin
grade 2 bilaterally (hippocampal atrophy).I  379
ery  variable.  The  leading  genetic  cause  is  due  to  a  muta-
ion of  the  tau  gene,  which  is  located  on  chromosome  17
35]. Signs  develop  insidiously,  and  may  be  dominated  by
ehavioral disorders,  altered  personality,  and  loss  of  empa-
hy and  motivation.  Loss  of  planning  and  judgment  may
ead affected  individuals  to  give  up  work  early  and  is  often
ttributed by  their  families  to  relationship  difﬁculties  or
epression, which  can  delay  the  diagnosis.  Three  clinical
orms of  FTLD  are  described  [31]  depending  on  the  predomi-
ant signs:  frontotemporal  dementia  (behavioral  disorders),
rimary progressive  nonﬂuent  aphasia  and  semantic  demen-
ia (language  difﬁculties).  Unlike  AD,  FTLD  is  associated  with
n early  onset  of  behavioral  [5]  or  language  difﬁculties  (in
his case,  primary  progressive  aphasia  or  semantic  demen-
ia) whereas  memory  and  spatial  orientation  difﬁculties  are
ot the  main  features.
The  presentation  in  frontotemporal  dementia  predomi-
antly involves  a  gradual  deterioration  in  behavior  (apathy,
isinhibition and  lapses  of  concentration)  and  character.  On
RI,  atrophy  is  seen  in  the  frontal  lobes,  particularly  the
rontal orbital  cortex  and  the  anterior  part  of  the  temporal
obes (Fig.  4)  [36].  ASL  shows  hypoperfusion  in  the  frontal
ortical regions  [37].
Primary  progressive  nonﬂuent  aphasia  is  characterized  by
n insidious  gradual  reduction  in  spontaneous  verbal  expres-
ion with  anomia  and  agrammatism,  but  preserved  memory
38]. Other  cognitive  functions  are  also  preserved  in  the
arly stages  of  the  disease.  On  MRI,  atrophy  is  seen  in  the
nferior frontal  and  left  antero-superior  temporal  regions,
nd predominantly  in  perisylvian  regions  (Fig.  5)  [39].
Severe  difﬁculties  in  understanding  words  and  naming
re seen  in  semantic  dementia.  Grammatical  aspects  of
anguage, visuospatial  praxias  and  episodic  memory  are  pre-
erved. MRI  shows  abnormalities  mostly  affecting  the  left
nterior temporal  region,  although  bilateral  changes  may  be
een (Fig.  6).  This  asymmetry  and  the  presence  of  an  antero-
osterior gradient  distinguish  semantic  dementia  from  AD
40]. Selective  right  anterior  temporal  atrophy  has  occa-
ionally been  described,  characterized  clinically  by  gradual
ily history (mother and three brothers): a: axial T1-weighted MR:
g the parietal region; b: coronal T1-weighted MR: Scheltens scale:
380  C.  Quach  et  al.
Figure 3. A 64-year-old woman with Alzheimer’s disease (amnesic form): a: coronal T1-weighted MRI: assessment of hippocampal struc-
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paces; c: arterial spin labeling perfusion MRI. Reduced cerebral bl
ifﬁculty  interpreting  facial  expressions  and  emotions,  loss
f empathy  and  behavioral  disorders  [41].
ewy body dementia
ewy  body  dementia  (LBD)  is  associated  with  abnormal
euroﬁlament protein  aggregation  (ubiquitin  and  alpha-
ynuclein) in  neurons  [42].  It  is  rare  before  the  age  of  65,
nd presents  clinically  in  young  people  with  a  combination
f ﬂuctuating  cognitive  difﬁculties,  visual  hallucinations  and
arkinsonism [43].  The  full  clinical  presentation  is  rarely
een in  the  initial  stage  of  the  disease.  It  should  be  diag-
osed early  as  patients  are  hypersensitive  to  neuroleptics,
hich therefore  need  to  be  avoided.  MRI  shows  cortical  and
ubcortical atrophy  without  any  speciﬁc  features  (Fig.  7).
he differential  diagnosis  between  LBD  and  AD  or  Parkinson’s
isease (PD)  with  dementia  is  not  always  straightforward  as
H
t
t
a b: axial T1-weighted MRI: diffuse enlargement of the subarachnoid
ow in the parietal regions (arrows).
he  imaging  ﬁndings  may  be  similar  in  LBD  and  PD.  The  diag-
osis of  LBD  is  suggested  if  dementia  occurs  within  a  year
fter extrapyramidal  signs  develop  [44].  The  distinction  with
D is  more  difﬁcult  as  memory  problems  and  medial  tempo-
al atrophy  may  only  develop  secondarily  in  the  early  stages
f AD  in  this  age  group  [45].  Perfusion  cerebral  scintigraphy
n LBD  shows  diffuse  cortical  hypoperfusion  of  the  tracer
nd DaTSCAN® (Ioﬂupane  [123I])  shows  reduced  uptake  in  the
entral gray  nuclei  due  to  dopaminergic  denervation  (Fig.  8)
46].
untington’s diseaseuntington’s  disease  is  an  inherited  neurodegenerative  cen-
ral nervous  system  disorder  which  predominantly  affects
he central  gray  nuclei  (with  loss  of  GABAergic  neurons  and
strogliosis). It  is  transmitted  as  an  autosomal  dominant
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Figure 4. Fronto-temporal dementia in a 62-year-old woman.
Axial  T1-weighted MRI: enlargement of the subarachnoid spaces in
Figure 6. Semantic dementia in a 65-year-old woman. Axial
T2-weighted FLAIR images. Bilateral anterior temporal atrophy
(pronounced enlargement of the subarachnoid spaces combined
w
p
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m
of the  caudate  nuclei  and  enlargment  of  the  frontal  hornsthe frontal regions. Dilatation of the ventricular system, predomi-
nantly  affecting the frontal horns.
disease  with  complete  penetrance.  The  mutated  gene,
which codes  for  the  huntingtin  protein,  is  located  on  the
short arm  of  chromosome  4  [47].  De  novo  mutations,
although rare,  may  occur.  It  has  a  prevalence  of  ﬁve  to  seven
people per  100,000  in  the  Caucasian  population  [48]  and  has
two  forms:  the  juvenile  form  beginning  before  the  age  of
20 and  the  late  form  starting  at  around  40  years  old.  The
onset is  often  insidious  and  characterized  by  cognitive  or
(
o
p
Figure 5. Primary progressive aphasia in a 63-year-old woman: a: co
affecting the left side. Frontal white matter hypointensities due to asso
perisylvian atrophy (enlargement of the frontal cortical and anterior temith  dilatation of the temporal horns).
sychiatric  problems  (depression)  [49]  preceding  the  chor-
iform movements.
MRI shows  atrophy  of  the  caudate  nucleus  and  puta-
ens, with  a  loss  of  the  usually  clearly  convex  appearanceFig. 9)  [50].  The  central  gray  nucleus  may  be  hyperintense
n T2-weighted  MRI  in  juvenile  forms  of  the  disease.  Atro-
hy then  extends  to  the  globi  pallidi,  thalami,  cortex  and
ronal T1-weighted MR: bilateral temporal atrophy, predominantly
ciated leukoaraiosis; b: sagittal T1-weighted left lateral MR: left
poral sulci and the sylvian ﬁssure).
382  C.  Quach  et  al.
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Figure 9. Huntington’s disease in a 56-year-old woman. Coronal
T1-weighted MRI. Pronounced loss of volume of the head of the
caudate  nuclei (arrows) with an enlargement of the frontal horns.
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vigure 7. Lewy body dementia. Axial T1-weighted MRI. Diffuse
oderate enlargement of the subarachnoid spaces.
rain  stem,  causing  appearances  of  predominantly  frontal,
iffuse cerebral  atrophy.  The  disease  progresses  gradually  to
oss of  independence  and  death  over  an  average  of  ﬁfteen
o twenty  years.  It  progresses  faster  in  earlier  onset  disease.
igure 8. DaTSCAN®. Tracer-uptake defects in the posterior
egion of the central gray nuclei (arrows).
a
d
a
g
p
a
p
i
r
t
p
P
P
e
t
i
[
C
a
c
C
a
c
s
t
w
bnlargement of the subarachnoid spaces, frontal convexity, inter-
emispheric  scissure, sylvian regions and choroid ﬁssures.
he  deﬁnitive  diagnosis  is  made  by  molecular  biology  (triplet
xpansion in  the  IT15  gene).
orticobasal degeneration
orticobasal  degeneration  is  a  neurodegenerative  disease
ery occasionally  seen  in  the  dementia  stage  before  the
ge of  65.  It  involves  neuroﬁbrillary  degeneration,  pre-
ominantly in  the  cortical  and  subcortical  frontal  regions
ssociated with  accumulation  of  tau  proteins.  The  sug-
estive clinical  signs  include  asymmetrical  motor  disorders
redominantly in  the  upper  limbs,  sensory  abnormalities
nd apraxia.  MRI  shows  frontoparietal  cortical  atrophy,
redominantly in  the  paracentral  region  (Fig.  10).  Hyper-
ntensities on  T2-weighted  MR  may  be  seen  in  the  motor
egion (cortex  and  subcortical  white  matter).  Hyperintensi-
ies on  T2-weighted  imaging  have  also  been  reported  in  the
osterior part  of  the  putamens  and  substantia  nigra  [51].
rion dementia
rion  diseases  are  transmissible  neurodegenerative  dis-
ases characterized  by  diffuse  cerebral  spongiosis  secondary
o abnormal  ﬁbrillar  glycoprotein  (PrP)  deposition.  This
s coded  by  the  PNRP  gene  located  on  chromosome  20
52]. Human  prion  diseases,  the  most  common  of  which  is
reutzfeldt-Jakob (CJD),  may  be  sporadic  (90%  of  cases),
cquired (iatrogenic)  or  genetic  [53].  The  familial  forms
annot be  distinguished  clinically  from  sporadic  disease.
DJ is  suggested  by  rapidly  progressive  dementia  (over
 few  weeks)  and  development  of  suggestive  neurologi-
al signs  (myoclonia,  ataxia,  pyramidal  and  extrapyramidal
igns). The  new  variant  form  of  the  disease  (vCJD),  iden-
iﬁed for  the  ﬁrst  time  in  the  United  Kingdom  in  1996,
as transmitted  by  eating  beef  from  herds  infected  with
ovine spongiform  encephalopathy.  This  affects  younger
Early-onset  dementias:  Speciﬁc  etiologies  and  contribution  of  MR
Figure 10. Basal cortical degeneration in a 62-year-old woman.
Axial  T2-weighted FLAIR MR. Asymmetrical enlargement of the sub-
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hypoperfusion. The  diagnosis  of  vascular  dementia  due  toarachnoid  spaces predominantly in the right parietal region and
paracentral  regions.
people  between  30  and  40  years  old  and  characteristi-
cally causes  dementia  in  the  early  stages  of  the  disease
[54]. Electroencephalography  in  advanced  sporadic  forms  of
the disease  (sCJD)  (unlike  vCJD)  often  shows  characteristic
triphasic periodic  complexes.  CSF  analysis  shows  markers  of
rapid neuronal  destruction,  such  as  high  levels  of  protein
m
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Figure 11. Creutzfeldt-Jakob disease, sporadic form. Axial diffusion-w
nuclei and lenticular nuclei (b) (arrows).I  383
4-3-3.  T2  and  diffusion-weighted  MR  in  the  sporadic  form
f the  disease  shows  bilateral  and  symmetrical  hyperinten-
ities in  the  central  gray  nuclei,  thalamus,  cerebral  cortical
ibbon (particularly  in  the  frontal  and  temporal  lobes)  and
n the  cerebellum  (Fig.  11)  [55].  Diffusion-weighted  MRI
s the  most  sensitive  method  in  terms  of  detecting  single
bnormalities [56].  In  familial  disease,  the  cortical  hyper-
ntensity on  a diffusion-weighted  sequence  may  even  be
resent before  clinical  signs  develop  [57].  In  vCJD,  the  char-
cteristic ﬁnding  is  hyperintensity  in  the  pulvinar  nuclei  and
orso-median thalamic  nuclei  (‘‘hockey-stick’’  appearance)
Fig. 12)  whereas  a  cortical  hyperintensity  is  rarely  present
58,59]. Ninety  percent  of  affected  people  die  within  a  year
f diagnosis.  The  deﬁnitive  diagnosis  is  histological:  in  the
ew variant  form  of  the  disease,  the  diagnosis  can  be  made
rom tonsillar  biopsy  from  immunological  labeling  of  the
rion protein  [60]  although  brain  tissue  examination  is  still
eeded for  sporadic  CJD.
ascular dementia
ascular  dementia  (VD)  is  the  second  leading  cause  of  early-
nset dementia  [4],  and  includes  all  forms  of  dementia
hich are  secondary  to  cerebrovascular  damage.  Various
linical and  pathological  presentations  have  been  described
epending on  the  site  and  appearance  of  the  cerebral
esions: VD  due  to  multiple  cerebral  infarctions  is  due  to
trategic infarctions,  subcortical  ischemic  VD  with  Cere-
ral Autosomal  Dominant  Arteriopathy  with  Subcortical
nfarcts and  Leukoencephalopathy  (CADASIL),  VD  secondary
o multiple  hemorrhagic  lesions  and  VD  due  to  cerebralultiple infarctions  was  described  initially  by  Hachinski
t al.  [61]  and  is  based  on  the  combination  of  cardiovascu-
ar risk  factors,  sudden  onset  and/or  stepwise  progression
eighted MRI (a, b). Hyperintensity in the cortical band (a), caudate
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Figure 12. New variant form of Creutzfeldt-Jakob disease. Diffusion (a) and FLAIR images (b). Hyperintensity in the pulvinar and dorso-
median thalamic nuclei (arrows) producing a ‘‘hockey-stick’’ appearance.
with  focal  signs  on  clinical  examination.  The  infarctions
may be  due  to  occlusion  of  the  large  or  medium  cerebral
arteries (extensive  parenchymal  infarction)  and/or  small
arteries (perforating  arteries  causing  focal  infarction  within
the white  matter  or  central  gray  nuclear  region)  (Fig.  13).
VD  due  to  strategic  infarctions  or  single  vascular  lesions
occurs in  territories  involved  in  cognition  or  memory.  The
various territories  involved  are  cortical  (left  angular  gyrus,
mesial part  of  the  left  temporal  lobe  [62],  median  part  of  the
Figure 13. Multiple infarctions in a 63-year-old man. Axial T2-
weighted  FLAIR MRI. Old infarctions in the left frontal region and
right  parietal region.
frontal  lobes)  and  subcortical  regions  (thalamus,  particularly
the left)  (Fig.  14).
Ischemic subcortical  VD  refers  to  two  former  diagnoses,
Binswanger’s encephalopathy  [63]  and  lacunar  dementia
Figure 14. Strategic infarction. Axial T1-weighted image. Old
bithalamic  infarctions (arrows) (infarction in the territory of the
artery  of Percheron).
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[64].  These  are  now  deﬁned  by  the  revised  NINDS-AIREN
criteria [65]  and  on  MRI,  show  image  abnormalities  in  the
white matter  (T2-weighted  spin  echo  and  FLAIR  hyperin-
tensities due  to  leukoaraiosis),  lacunar  infarctions  (cavities
under 15  mm  in  size,  with  the  same  appearances  as  CSF  on
all sequences,  located  in  the  territory  of  the  perforating
arteries) and  by  microbleeds  (hypointensities  under  a  cen-
timeter in  size  on  T2-weighted  gradient-echo  sequences).
Sporadic (arteriolosclerosis,  less  commonly  vasculitis)  and
genetic causes  (the  leading  cause  of  which  is  CADASIL)  are
seen. CADASIL  is  due  to  a  mutation  of  the  NOTCH  3  gene
[66], which  is  located  on  chromosome  19  [67].  Sporadic
cases of  the  disease  have  also  been  described  [68].  Clinical
presentations are  extremely  variable  between  affected  indi-
viduals  and  within  the  same  family.  The  signs  and  symptoms
may include  migraine  with  aura  beginning  between  20  and
40 years  old  [69],  mood  disturbances,  apathy  [70],  recurrent
subcortical ischemic  events  after  40  years  old,  and  cognitive
disturbances [71].  The  earliest  and  most  common  abnor-
mal appearances  are  hyperintensities  on  T2-weighted  FLAIR
sequences in  the  white  matter,  which  can  be  seen  from  the
age of  20  to  30  years  old.  These  are  located  in  the  periven-
tricular regions,  the  semi-oval  centers,  the  external  capsule
and the  anterior  part  of  the  temporal  lobes  (Fig.  15)  [72,73].
Temporal lobe  involvement  is  seen  in  more  than  two-third
of patients.  The  central  gray  nuclei  and  thalami  may  be
affected [74].  Lacunar  infarctions  are  seen  as  ﬂuid  micro-
cavities with  restricted  diffusion  if  they  are  recent  [75].
Microbleeds are  present  and  appear  as  hypointensities  on
T2-weighted gradient-echo  sequences  [5,76].  The  disease  is
conﬁrmed by  testing  for  the  NOTCH  3  gene  mutation.
VD  secondary  to  multiple  hematomas  is  usually  due
to severe  forms  of  amyloid  angiopathy  (AA).  T2-weighted
gradient-echo MR  shows  multiple  hypointensities  (microb-
leeds), typically  located  in  the  cortex  and  subcortical
regions, combined  with  lobar  hematomas  of  various  ages
b
T
t
Figure 15. CADASIL in a 34-year-old woman. Axial T2-weighted FLAIR
subcortical periventricular white matter (a). Anterior subcortical tempoI  385
Fig.  16).  White  matter  demyelination  is  often  also  present.
his is  a  rare  diagnosis  in  young  people  and  should  suggest
n autosomal  dominant  familial  form  of  the  disease  (muta-
ion of  the  APP  gene  located  on  chromosome  21  [77]  or  of
he BRI  gene  located  on  chromosome  13  [78,79]).  Vascular
ementia due  to  cerebral  hypoperfusion  is  seen  in  situations
nvolving low  blood  ﬂow  velocity,  causing  ischemic  damage
o the  junctional  territories.  As  they  are  located  in  two
ifferent vascular  drainage  areas,  the  external  junctional
nfarctions (cortical)  can  be  distinguished  from  the  internal
nfarctions (subcortical)  [80].  The  external  infarctions  at  the
unction of  the  territories  of  the  Circle  of  Willis  at  the  base
f the  brain  are  peripheral  and  have  a  triangular  cortical
orphology (Fig.  17)  whereas  the  internal  infarctions  at  the
unction of  the  cortical  and  perforating  branches  of  the  same
rtery have  a  linear  morphology  and  are  located  in  the  white
atter.
Dural arteriovenous  ﬁstulae  draining  into  cortical  veins
re also  a  cause  of  dementia,  which  presents  subacutely.
hese are  acquired  arterio-venous  communications  within
he dura  mater,  supplied  by  meningeal  arteries  arising
ostly from  the  external  carotid  system  [81].  They  are
sually located  in  the  transverse  sinus  and  sigmoid  regions
82] and  generally  occur  secondarily  to  a  sinus  thrombosis
83]. Increased  venous  pressure  due  to  turbulence  and  sinus
hrombosis is  transmitted  in  a  retrograde  manner  to  the  cor-
ical veins  with  a  risk  of  hemorrhage,  congestion  and  venous
schemia. The  ﬁstula  presents  via  dementia  in  approximately
0% of  cases  [83],  in  which  case  symptoms  are  due  to  chronic
enous ischemic  damage  (low  blood  ﬂow  velocity  because
f ﬂow  reversal  in  the  veins  draining  the  encephalon)  [81].
eadaches are  associated  with  signs  of  cognitive  deteriora-
ion. MRI  shows  ﬂow  abnormalities  within  the  venous  sinuses
y thrombosis  or  stagnation  and  dilated  cortical  veins  [84].
he sinus  may  enhance  in  chronic  thrombosis.  White  mat-
er edema  reﬂecting  the  raised  venous  pressure  may  also
 image (a, b). Multiple nodular hyperintensities in the deep and
ral hyperintensities (b).
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Figure 16. Amyloid angiopathy in a 59-year-old woman. Axial T2-weighted gradient-echo MRI: multiple cortical micronodular hypointen-
sities (micro-bleeds) (a, b). Left parietal hematoma: hyperintensity surrounded by hemosiderin (b). Note the opening of the hematoma
into the adjacent subarachnoid space with superﬁcial hemosiderosis seen
(arrow).
develop  [84].  Dynamic  MR  angiography  performs  better  in
this situation  than  time  of  ﬂight  MR  angiography  and  can
diagnose by  visualizing  the  ﬁstula  which  is  seen  as  contrast
product passing  from  an  arterial  to  a  venous  segment  [85].
The reference  investigation  to  establish  the  architecture  of
the ﬁstula  is  still  conventional  angiography.  Cognitive  func-
tion can  be  restored  by  treatment,  the  ﬁrst  line  of  treatment
is an  endovascular  approach  [86].
Figure 17. Old junctional infarctions. Axial T2-weighted MRI.
Hyperintensities in the cortex and white matter at the junction of
different  arterial territories.
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lcohol-related dementia
radual  intellectual  deterioration  is  one  of  the  psychiatric
nd neurological  complications  of  chronic  alcoholism  and
nvolves defects  in  executive  functions  and  autobiographic
emory and  confabulation.  The  concept  of  alcohol-related
ementia raises  diagnostic  difﬁculties  as  many  patients
ave clinical  signs  of  the  Wernicke-Korsakoff  syndrome
thiamine deﬁciency),  nutritional  deﬁciencies  and  hepatic
ncephalopathy. Dementia  occurring  secondary  to  chronic
lcohol use  is  multifactorial  in  origin,  with  a  direct  toxic
ffect of  the  alcohol  which  easily  crosses  the  blood-
rain barrier,  alcohol-related  deﬁciencies,  repeated  head
njuries, seizures  with  anoxia,  ischemic  vascular  accidents
nd particularly  hemorrhages.
In  chronic  alcoholism,  MR  shows  diffuse  cerebral  atrophy
ith cortical  atrophy  predominantly  in  the  fronto-parietal
egions (hippocampal  atrophy  proportional  to  the  overall
eduction in  cerebral  volume  [87]),  cerebellar  atrophy,  pre-
ominantly in  the  superior  vermis  and  paravermal  area.
ther more  speciﬁc  abnormalities  may  be  present,  includ-
ng atrophy  of  the  central  gray  nuclei  and  mamillary  bodies
Korsakoff syndrome),  abnormal  corpus  callosum  appear-
nces (Marchiafava-Bignami  disease)  and  abnormalities  of
he central  part  of  the  pons  (as  a  result  of  central  pontine
yelinolysis) (Fig.  18).
nfectious diseases
he  infectious  diseases  which  usually  cause  subacute
ementia associated  with  focal  neurological  signs  and
equire a  speciﬁc  assessment,  guided  by  the  clinical  picture.
irst line  investigations  for  early-onset  dementia  include
uman immunodeﬁciency  virus  (HIV)  and  syphilis  serologies.
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Figure 18. Chronic alcohol abuse in a 50-year-old man: a: axial T2-weighted FLAIR image: diffuse enlargement of the cortical sulci; b:
llar atrophy predominantly affecting the superior vermis. Hyperintensity
Inﬂammatory and autoimmune diseases
Amongst  the  causes  of  sporadic  early-onset  dementia,
inﬂammatory and  autoimmune  diseases,  including  multiplesagittal T2-weighted MRI: atrophy of the corpus callosum and cerebe
in the pons due to centro-pontine myelinolysis.
AIDS dementia complex
Brain  disease  secondary  to  direct  nervous  system  attack
by the  HIV  virus  usually  presents  as  subcortical  dementia
associated with  walking  difﬁculties  and  seizures.  The  cog-
nitive decline,  which  is  often  a  presenting  feature  of  the
disease, occurs  when  the  patient  infected  with  the  virus
becomes immunosuppressed  when  the  CD4  count  is  low
(< 200/mm3).  MRI  shows  diffuse  cerebral  atrophy,  initially
predominantly in  the  subcortical  region.  The  extent  of  ven-
tricular enlargement,  particularly  in  the  caudate  nucleus
region, is  reported  to  correlate  with  poor  performance  in
neurophsychological tests  [88].  This  is  very  often  associated
with periventricular  white  matter  hyperintensities  (particu-
larly in  the  corpus  callosum)  [89]  or  diffuse  hyperintensities
in the  white  matter  with  preservation  of  the  U-ﬁbers
(Fig. 19)  [90—92].
Neurosyphilis
Neurosyphilis  is  a  neurological  disease  which  develops  in
the late  stage  of  syphilis  (a  third  of  patients  have  ter-
tiary syphilis).  It  is  characterized  by  behavioral  problems
including agitation,  abnormal  social  behavior  and  memory
and attention  difﬁculties.  The  cortical  dementia  develops
gradually. MRI  of  such  presentations  of  dementia  shows  atro-
phy of  the  medial  temporal  regions  similar  to  that  which  is
found in  AD  [93,94],  abnormal  intensities  in  the  same  region
with T2-weighted  hyperintensity  similar  to  herpes  or  lim-
bic encephalitis  [95,96].  Vasculitic  disorders  and  meningeal
enhancement may  also  be  present.  The  diagnosis  is  con-
ﬁrmed by  blood  and  CSF  tests  (TPHA  and  VDRL).
Figure 19. A 55-year-old man infected with the human
immunodeﬁciency virus. Axial T2-weighted FLAIR MRI: diffuse
hyperintensities in the white matter with preservation of the
U-ﬁbers  (arrows), pronounced enlargement of the subarachnoid
spaces.
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Figure 20. Primary central nervous system angiitis. Axial T2-
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the median  temporal  lobes  are  preferentially  affected,  the
inferior frontal  regions,  insular  cortex  and  cingulate  cor-
tex can  also  be  affected.  Limbic  encephalitis  is  caused  by88  
clerosis  (MS),  lupus,  Behc¸et’s  disease  and  sarcoidosis,  are
ccasionally responsible  for  isolated  cognitive  problems  and
enerally do  not  raise  diagnostic  difﬁculties  once  cognitive
roblems have  developed  [2].  MS  (one  of  the  most  common
auses of  secondary  dementia),  Sjögren’s  syndrome  and  pri-
ary  angiitis  of  the  central  nervous  system  (CNS)  are  all
iseases which  can  present  with  cognitive  problems.
ultiple sclerosis
ultiple  sclerosis  rarely  presents  with  cognitive  problems,
lthough these  are  common  in  the  late  stages  of  the  dis-
ase [97—99]  and  progress  slowly.  They  are  more  severe
n progressive  rather  than  remittent  disease  and  correlate
ith the  topography  of  the  lesions,  total  lesion  burden
nd axonal  disease  [100,101].  The  cortical  and  subcortical
esions are  reported  to  contribute  most  to  cognitive  decline
n these  patients  [102,103].  Subcortical  damage  is  due  to
eterioration of  the  U-ﬁbers  which  are  involved  in  the
nterconnections between  different  cortical  regions  [100].
he extent  of  corpus  callosum  atrophy  correlates  with  the
egree of  axonal  damage  [99].  Extensive  damage  to  the
hite matter  causes  fronto-subcortical  disconnection,  with
 decline  in  executive  functions.
jögren’s syndrome
jögren’s  syndrome  is  a  chronic  autoimmune  disease,  which
redominantly affects  females  (sex  ratio  9:1)  which  may
resent initially  with  mild  frontal  subcortical  cognitive  dis-
urbance. MR  shows  non-speciﬁc  nodular  lesions  which  are
yperintense on  T2-weighted  MR  in  the  white  matter,  of
ariable topography  (periventricular,  deep  or  subcortical),
nd associated  with  diffuse  cortical-subcortical  atrophy.  As
t improves  with  corticosteroid  therapy,  anti-Ro/SSA  and
nti-La/SSB antibodies  should  be  measured  and  an  acces-
ory salivary  biopsy  should  be  performed  if  any  suspicion  is
resent [104].
rimary angiitis of the central nervous system
he  diagnosis  of  cerebral  vasculitis  is  relatively  straightfor-
ard if  the  disease  involves  multiple  systems  (hence  the  use
f  renal,  liver  and  opthalmological  assessments)  although  it
s more  difﬁcult  when  it  is  restricted  to  the  central  nervous
ystem as  is  seen  in  primary  angiitis  of  the  CNS,  the  cause  of
hich is  still  unknown.  Focal  inﬂammatory  changes  (granu-
omatous, necrotizing  and/or  lymphocytitic)  preferentially
ffect the  small  leptomeningeal  and  intraparenchymal  ves-
els. Clinical  presentations  vary  greatly  from  acute  ‘‘pseudo
S’’ encephalopathy  or  very  gradual  subcortical  demen-
ia. Headaches  are  commonly  associated,  although  may
ot be  present.  MRI  shows  secondary  vascular  lesions
ue to  arteritis,  appearing  as  plaques  of  demyelination,
nfarctions, bleeds  (microbleeds  and  hematomas)  (Fig.  20).
arietal involvement  may  be  seen  as  thickening  or  contrast
nhancement of  the  vascular  walls.  MR  angiography,  and
articularly arteriography  (Fig.  21),  shows  stenosis  and/or
ctasia (pearl  necklace  appearance)  in  small  diameter  arter-
es. Raised  inﬂammatory  markers  and  auto-antibodies,  MRI
bnormalities,  pleiocytosis  with  oligoclonal  bands  in  the  CSF,
nd a  pearl  necklace  appearance  on  arteriography  suggest
F
c
eeighted  FLAIR MRI: hyperintensities in the white matter in both
emi-oval  centres, with right medial parietal infarction.
ngiitis,  although  none  of  these  signs  can  replace  histol-
gy, and  unconﬁrmed  suspected  cerebral  vasculitis  remains
ne of  the  indications  for  cerebromeningeal  biopsy,  before
onsidering immunosuppressant  therapy.
imbic encephalitis
he  limbic  encephalitides  are  a group  of  different  disorders
ith selective  involvement  of  the  limbic  system.  Althoughigure 21. Primary central nervous system angiitis. Lateral
arotid arteriography: multiple focal arterial stenoses and areas of
ctasia (arrows).
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dysimmune  (paraneoplastic  or  idiopathic)  or  infectious  (HSV
and HHV6  encephalitis)  conditions  (Fig.  22).
Dysimmune  limbic  encephalitis  is  a  rare  condition,  char-
acterized clinically  by  cognitive  and  anterograde  memory
problems which  may  be  combined  with  seizures  and  psy-
chiatric problems.  It  develops  subacutely  and  may  progress
to dementia.  CSF  analysis  shows  inﬂammation  with  mod-
erate pleiocytosis,  increased  cerebrospinal  ﬂuid  protein
and oligoclonal  bands.  MR  image  abnormalities  are  usu-
ally seen  the  anteromedial  temporal  cortex,  hippocampi
and amygdali,  and  appear  as  hyperintense  plaques  on  T2-
weighted sequences  with  no  space  occupying  effect  or
contrast enhancement.  The  MRI  may  initially  be  normal.  It
is essential  to  search  for  a  dysimmune  cause  by  measuring
speciﬁc serum  autoantibodies  against  intracellular  neuronal
components (anti-Hu,  anti-Ma2,  anti-CV2)  or  nervous  system
cell surface  antigens  (Voltage  Gated  Potassium  Channels,
anti-N-methyl-D-aspartate  receptor  antibodies)  if  the  clini-
cal and  radiological  features  are  suggestive,  after  excluding
infectious disease  [105].  Patients  found  to  have  autoimmune
limbic encephalitis  should  also  be  examined  for  a  coexistent
tumor (small  cell  lung  cancer  in  50%  of  cases,  testes,  breast,
thymoma or  lymphoma).  The  treatment  of  paraneoplastic
limbic encephalitis  involves  treatment  of  the  underlying
cancer and  initiation  of  immunotherapy.  Immunotherapy  has
also  been  shown  to  be  particularly  effective  in  idiopathic
dysimmune limbic  encephalitis  [106].
Metabolic diseases
Amongst  the  metabolic  diseases,  respiratory  chain  abnor-
malities due  to  a  mitochondrial  DNA  mutation  is  reported  to
represent approximately  half  of  the  cases  of  adult  dementia
occurring in  those  under  45  years  of  age  [8].  These  are  often
associated with  other  neurological  and  systemic  signs  seen  in
MELAS syndrome  (Mitochondrial  Encephalopathy  with  Lactic
Acidosis and  Stroke-like  episodes)  with  combined  myopa-
thy and  pseudo-cerebrovascular  accidents,  MERFF  syndrome
(Myoclonic Epilepsy  with  Ragged-Red  Fibers)  with  myoclonic
epilepsy, and  NARP  syndrome  (Neuropathy,  Ataxia,  Retinitis
p
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i
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Figure 22. Dementia secondary to infectious encephalitis (HHV6 herp
T2-weighted FLAIR MRI: a: hyperintensity in both hippocampi (arrows);
Severe atrophy predominantly affecting the left side with a normal MRI I  389
igmentosa).  In  MELAS  syndrome,  the  disease  usually  begins
n childhood  or  early  adulthood,  although  the  dementia  gen-
rally occurs  late.  Cases  presenting  in  adulthood  as  subacute
ementia with  myoclonia  have  been  reported  [107].  MRI
hows diffuse  cerebral  atrophy  (temporo-occipito-temporal
ortex with  preservation  of  the  medial  temporal  regions)
ombined with  multiple  T2  hyperintensities  in  the  deep
hite matter  and  in  the  region  of  the  central  gray  nuclei
Fig. 23).  Image  abnormalities  mimicking  ischemic  accidents
re seen  in  acute  episodes  (T2  and  diffusion-weighted  hyper-
ntensities affecting  the  cortex  and  white  matter  in  plaques
ith a  variable  apparent  diffusion  coefﬁcient)  and  pre-
ominantly in  the  parieto-occipital  regions.  Spectroscopy
ay help  by  showing  a  lactate  doublet  in  60  to  65%  of
ases (Fig.  24).  Other  diagnoses  to  be  considered  if  a  cere-
rovascular accident  (CVA)  or  pseudo-CVA  is  present,  include
etabolic homocysteine  and  urea  cycle  abnormalities.
ilson’s disease
ilson’s  disease  is  a  curable  cause  of  early-onset  demen-
ia which  the  patient  needs  to  be  examined  for.  It  is  an
utosomal recessive  genetic  disease  which  has  an  esti-
ated prevalence  of  1/50,000  [108].  It  is  caused  by
xcessive accumulation  of  copper,  particularly  in  the  liver
nd central  nervous  system.  Behavioral  and  personality
isorders, depression  and  cognitive  difﬁculties  are  com-
on. The  cognitive  difﬁculties  and  related  neurological
igns (tremor,  ataxia  and  dysarthria)  develop  around  the
econd and  third  decades  of  life.  Patients  are  examined
linically for  the  corneal  Kayser-Fleischer  ring  which  is
athognomonic, although  is  occasionally  only  visible  on  slit
amp examination.
MRI shows  symmetrical  T2  hyperintensity  or  hypointen-
ity in  the  putamens,  caudate  nuclei,  thalami  and  globi
allidi. The  analyses  of  axial  sections  passing  through  the
esencephalon are  examined  for  the  ‘face  of  the  giant
anda’ appearance  (mesencephalic  hyperintensity  on  the
eriphery of  the  red  nuclei)  (Fig.  25).  T2-weighted  hyper-
ntensities in  the  pons  and  pontocerebellar  bundles  may
ccur. The  diagnosis  is  conﬁrmed  by  laboratory  ﬁndings:
es group virus) in a 59-year-old immunosuppressed man. Coronal
 b: 5 months later. Reduction in size of both hippocampal bodies.
signal. Abnormal signal on the right persists.
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Figure 23. MELAS in an 18-year-old woman. Axial T2-weighted FLAIR MRI (a, b) and diffusion-weighted MR (c), mapping of apparent
diffusion coefﬁcient (d). Frontal hyperintensity on T2 and diffusion-weighted images (a, c) affecting the cortex and white matter (pseudo-
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tVA). The apparent diffusion coefﬁcient of the lesions was slightly 
f the central gray nuclei (putamens, caudate nuclei and thalami) a
educed  levels  of  serum  ceruloplasmin,  increased  levels  of
otal serum  and  urinary  copper  are  all  present.  This  can  be
reated with  a  life-long  course  of  copper  chelators.
euronal ceroid lipofuscinosis
his  is  a  group  of  neurodegenerative  diseases  secondary  to
ccumulation of  ceroid  lipopigments  in  neuronal  lysosomes.
t is  transmitted  as  an  autosomal  recessive  disease.  Four
ain forms  are  seen  based  on  clinical,  electrophysiologi-
al and  neuropathological  criteria:  the  early  childhood,  late
hildhood,  juvenile  and  adult  forms  of  the  disease  (also
nown as  Kufs  disease).  They  are  due  to  an  enzyme  deﬁ-
iency. The  gene  responsible  for  this  enzyme  deﬁciency  has
ot  yet  been  located  [109].
l
w
r
tased (mean ratio: 1.2). T2-weighted hyperintensities in the region
ubcortical matter in the parietal regions.
Symptoms  of  the  disease  begin  in  the  adult  form  at
round 30  years  old  with  myoclonic  epileptic  seizures
nd progressive  dementia,  ataxia  and  abnormal  move-
ents reﬂecting  damage  to  the  extrapyramidal  sys-
em.
MRI shows  hyperintensities,  particularly  in  the  periven-
ricular white  matter  on  T2-weighted  FLAIR  MRI  due  to  loss
f neuronal  integrity,  reactive  gliosis  and  increased  axonal
emyelination [109,110].  T2  gradient-echo  hypointensity
ay be  seen  in  the  central  gray  nuclei,  particularly  in  the
halamic and  putamen  nuclei  due  to  iron,  secondary  to  the
ipofuscin accumulation  (Fig.  26)  [111].  This  is  associated
ith diffuse  cortical  atrophy,  particularly  in  the  parietal
egions, which  may  extend  to  the  central  gray  nuclei  in
he late  stages.  Treatment  is  mostly  symptomatic.  Patients
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Figure 24. Spectroscopy (echo time: 35 ms, monovoxel pos-
itioned  in the left middle frontal region). Lactate doublet present
(arrow).
p
t
C
C
i
a
p
o
c
p
d
w
p
i
d
t
h
s
s
Figure 25. Wilson’s disease: a: axial T2-weighted MR: bilateral, symm
capsulothalamic regions); b: axial T2-weighted FLAIR MRI: mesencephali
of the giant panda’ appearance; c: immediately lower axial T2-weighted 
tegmentum and tectum.I  391
rogress  to  become  bed  bound  and  die  within  ten  years  after
he signs  appear.
ACH/VWM syndrome
hildhood  Ataxia  with  Central  Nervous  System  Hypomyelin-
sation/Vanishing White  Matter  (CACH/VWM)  syndrome  is
 recently  recognized  autosomal  recessive  leukodystro-
hy. Signs  usually  develop  before  the  age  of  5  years
ld. Later  forms  of  the  disease  which  begin  in  adoles-
ence or  adulthood  have  been  described,  with  an  insidious
resentation involving  isolated  behavioral  and  cognitive
isorders [112].  MRI  shows  diffuse  bilateral  symmetrical
hite matter  demyelination.  Supratentorial  involvement
redominates with  preservation  of  the  U-ﬁbers.  In  the
nfratentorial regions,  the  corticospinal  and  cerebellar  bun-
les are  affected.  FLAIR  MRI  shows  hypointense  cavities  in
he periventricular  frontal  and  occipital  regions  within  the
yperintensity (Fig.  27).
Other  metabolic  causes  may  be  responsible  for  progres-
ive dementia.  These  are  rare  and  their  MRI  features  are
hown in  Table  1.
etrical hyperintensities in the central gray nuclei (putamens and
c hyperintensity on the periphery of the red nuclei producing ‘face
FLAIR section with pronounced hyperintensity in the mesencephalic
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Figure 26. Kufs disease in a 59-year-old man: a: axial T2-weighted FLAIR MRI: diffuse cortical and subcortical atrophy. Hyperintensities in
the periventricular white matter close to the posterior part of the lateral ventricles; b: axial T2-weighted gradient-echo MRI: pronounced
hypointensity in the head of the caudate nuclei and lenticular nuclei.
Figure 27. CACH/VWM syndrome in a 33-year-old woman. Axial T2-weighted FLAIR MR FLAIR image: a: diffuse hyperintensity in the white
matter with preservation of the U-ﬁbers; b: hypointense cavity areas in the frontal periventricular regions (arrows).
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Table  1  MRI  features  of  different  metabolic  causes.
Metabolic  diseases  MRI  abnormalities
2-hydroxyglutaric  Hyperintensity  in  the  subcortical  white  matter  affecting  the  U-ﬁbers
Glutaric  aciduria,  type  1  Fronto-temporal  atrophy,  diffuse  leukoencephalopathy
Cerebral  adrenoleukodystrophy  Leukoencephalopathy  involving  the  splenium  of  the  corpus  callosum  and
then  parieto-occipital  region
Mitochondrial  cytopathies  (MELAS) Pseudo-CVA,  T2-weighted  hyperintensities  in  the  WM  and  CGN,
spectroscopy:  lactates
British  dementia  Periventricular  leukoencephalopathy
GM2  gangliosidosis  (adult  form)  Cerebellar  atrophy
Homocystinuria  CVA
Metachromatic  leukodystrophy  (adult  form)  Diffuse  butterﬂy-shaped  leukoencephalopathy
Fabry’s  disease  T1-weighted  hyperintensities  in  the  lateral  pulvinars
Kufs disease  (type-4  ceroid  lipofuscinosis)  Parietal  atrophy,  leukoencephalopathy,  T2  GE  hypointensities  in  the  CGN
Wilson’s  disease  Mesencephalic  T2-weighted  hyperintensity  on  the  periphery  of  the  red
nuclei  (‘‘face  of  the  giant  panda’’  appearance)
Pantothenate  kinase-associated
neurodegeneration(PKAN)
T2-weighted hypointensity  in  the  pallidus  with  central  hyperintensity
(‘‘tiger  eye’’  appearance)
Neuroferritinopathy  T2-weighted  hypointensity  affecting  the  globi  pallidi
Type C  Niemann-Pick’s  disease  Parenchymal  atrophy,  T2-weighted  hyperintensities  in  the  white  matter
Phenylketonuria  Leukoencephalopathy  predominantly  affecting  the  parieto-occipital
region
CACH/VWM  syndrome  Diffuse  leukoencephalopathy,  periventricular  area  cavities
Cerebrotendinous xanthomatosis  Leukoencephalopathy,  T2-weighted  hyperintensities  in  the  dentate  nuclei
MELAS: Mitochondrial Encephalopathy with Lactic Acidosis and Stroke-like episodes; CVA: cerebrovascular accident; WM:  white matter;
CGM: central gray nuclei; GE: gradient echo; CACH/VWM: Childhood Ataxia with Central nervous system Hypomyelinisation/Vanishing
aWhite  Matter.Conclusion: diagnostic algorithms
MRI  is  a  key  stage  in  investigating  the  cause  of  early-
onset dementia.  These  need  to  be  acquired  following
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eighted volume  acquisitions  can  be  used  to  investigate
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ippocampus  in  order  to  allow  better  medial  tempo-
al examination,  sagittal  and  axial  sequences  to  assess
he topography,  to  study  the  anteroposterior  gradient
nd to  investigate  whether  or  not  aysmmetrical  atro-
hy, which  is  characteristic  of  degenerative  disease,  is
resent. The  topography  of  the  hyperintensity  on  T2-
eighted FLAIR  sequences  (Fig.  29)  can  suggest  a  diagnosis
f vascular  leucopathy  (subcortical,  external  capsule  and
ontine hyperintensity),  metabolic  (bilateral  symmetrical
s
p
d
igure 29. Diagnostic algorithm for T2-weighted FLAIR image abnorm
igure 30. Diagnostic algorithm for T2-weighted gradient-echo abnormC.  Quach  et  al.
yperintense  plaques  and/or  affecting  the  corticospinal
undles and  cerebellum),  inﬂammatory  or  infectious
asymmetrical periventricular,  juxtacortical,  nodular  hyper-
ntensity, possibly  with  enhancement).  On  T2-weighted
radient-echo MRI  (Fig.  30),  micronodular  hypointensities
microbleeds) suggest  a  vascular  cause.  Hypointensities
peciﬁcally affecting  the  central  gray  nuclei  indicate
aramagnetic deposition  characteristic  of  a  metabolic
isease. A  diffusion-weighted  hyperintensity  (Fig.  31)
alities.
alities.
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ormFigure 31. Diagnostic algorithm for diffusion-weighted image abn
may  be  due  to  vascular  disease,  CJD  or  mitochondrial
disease.
MRI can  therefore  be  used  to  determine  the  likely  cause
of the  dementia  (degenerative,  vascular,  infectious,  inﬂam-
matory, metabolic  or  toxic).  Once  the  obvious  causes  have
been excluded,  it  will  guide  investigation  into  the  rare
but characteristic  causes  of  early-onset  dementia,  some
of which,  notably  the  metabolic  and  autoimmune  causes,
require speciﬁc  management  and  involve  genetic  counsel-
ing.
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